Las Vegas, NV -- (SBWIRE) -- 01/02/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Geron Corporation (NASDAQ:GERN), Myriad Genetics, Inc.(NASDAQ:MYGN), Allied Nevada Gold Corp.(NYSEMKT:ANV), CYS Investments Inc(NYSE:CYS)
Geron Corporation (NASDAQ:GERN) was a volume gainer of 3.12 million shares and the average volume of the stock remained 5.77 million shares. The stock opened the session at $4.79 and finished at the end of the day at $4.74 and the stock decline -0.63%.The market capitalization of the stock remained 611.31 million. Geron Corporation is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California.
Has GERN Found The Bottom And Ready To Gain Momentum? Find Out Here
In the preceding trading session, Myriad Genetics, Inc.(NASDAQ:MYGN) exchanged 3.10 million shares and the average volume remained 2.61 million shares. The stock closed the session at $20.98 with the gain of 0.91%. Myriad Genetics, Inc., a molecular diagnostic company, focuses on the development and marketing of predictive medicine, personalized medicine, and prognostic medicine tests primarily in the United States. Myriad Genetics, Inc. was founded in 1991 and is headquartered in Salt Lake City, Utah.
Will MYGN Continue To Move Higher? Find Out Here
Allied Nevada Gold Corp.(NYSEMKT:ANV) enhanced 4.41% and its closing price was $3.55. The volume of the stock was 2.98 million shares and the average volume remained 3.37 million shares. The market capitalization of the stock remained 369.01 million. The beta of the stock remained 1.03. Allied Nevada Gold Corp., a gold and silver producer, focuses on the mining, development, and exploration of properties in Nevada. The company?s principal products include unrefined gold and silver bars.
Why Should Investors Buy ANV After The Recent Gain? Just Go Here and Find Out
CYS Investments Inc(NYSE:CYS) was a volume gainer of 2.97 million shares and the average volume of the stock remained 2.95 million shares. The stock opened the session at $7.32 and finished at the end of the day at $7.41 and the stock escalated 0.82%.The market capitalization of the stock remained 1.24 billion. CYS Investments, Inc., a specialty finance company, invests in residential mortgage pass-through certificates in the United States. It also focuses on investing in residential mortgage-backed securities that are issued and the principal and interest of which are guaranteed by a federally chartered corporation (Agency RMBS).
For How Long CYS’s Gloss will Attract Investors? Find out via this report
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)